chadsvasc hasbled calculator

Use this calculator to estimate CHA2DS2-VASc (stroke risk) and HAS-BLED (major bleeding risk) for adults with atrial fibrillation. Enter age, sex, and risk factors, then click calculate.

CHA2DS2-VASc Factors
HAS-BLED Factors

Please enter a valid age between 18 and 120.

For educational use only. Final decisions require clinical judgment and guideline-based care.

What this CHA2DS2-VASc + HAS-BLED calculator helps you do

When treating atrial fibrillation (AF), clinicians balance two competing risks: stroke risk if anticoagulation is not used, and bleeding risk if it is used. This page combines two of the most common bedside tools:

  • CHA2DS2-VASc: estimates annual ischemic stroke risk.
  • HAS-BLED: estimates major bleeding risk and flags modifiable risk factors.

Together, these scores support structured conversations between clinician and patient. They do not replace individualized evaluation.

How CHA2DS2-VASc is calculated

CHA2DS2-VASc assigns points based on common cardiovascular risk markers. Higher total scores generally indicate higher annual stroke risk in AF.

Component Points
Congestive heart failure1
Hypertension1
Age ≥75 years2
Diabetes mellitus1
Prior stroke/TIA/thromboembolism2
Vascular disease1
Age 65–74 years1
Sex category (female)1

Interpreting CHA2DS2-VASc in practice

In broad terms, higher scores support stronger consideration for oral anticoagulation (OAC). For females, a score of 1 due only to sex category is often considered low risk and usually does not alone trigger OAC.

How HAS-BLED is calculated

HAS-BLED focuses on bleeding risk and, importantly, on factors that can be corrected. The goal is risk reduction, not automatic withholding of anticoagulation.

  • Uncontrolled blood pressure control
  • Renal/liver dysfunction review
  • INR stability improvement (if on VKA)
  • Medication interaction cleanup (e.g., NSAIDs)
  • Alcohol counseling when relevant

What a high HAS-BLED score means

A HAS-BLED score of 3 or more signals increased bleeding risk and need for closer follow-up, but it should prompt risk mitigation rather than reflexively avoiding anticoagulation in high-stroke-risk patients.

Using both scores together

A common approach is:

  • Estimate stroke risk (CHA2DS2-VASc)
  • Estimate bleeding risk (HAS-BLED)
  • Address modifiable bleeding risks
  • Align treatment with patient values and net clinical benefit
Important: Scores are decision-support tools, not stand-alone treatment orders. Kidney function, frailty, prior intracranial hemorrhage, malignancy, patient preferences, and local guideline updates all matter.

Frequently asked questions

Does a high HAS-BLED score mean “no anticoagulation”?

Not necessarily. It means “be careful and correct what you can.” Many high-stroke-risk patients still benefit from anticoagulation when modifiable bleeding risks are managed.

Can I use this calculator for valvular AF or mechanical valves?

Use caution. These scores were primarily validated in non-valvular AF populations and should be applied within proper clinical context.

Should patients self-manage treatment decisions from this page?

No. This is educational content intended to structure clinician-patient discussions, not direct self-prescribing or medication changes.

🔗 Related Calculators